R Ntuyahaga, K El Husseini, I Ba, M P Debray, H Morel, C Kannengiesser, B Crestani, R Borie, Q Philippot
{"title":"[Unfavorable prognosis of pathogenic variants in the telomerase complex in cases of familial pulmonary fibrosis].","authors":"R Ntuyahaga, K El Husseini, I Ba, M P Debray, H Morel, C Kannengiesser, B Crestani, R Borie, Q Philippot","doi":"10.1016/j.rmr.2026.09.008","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.09.008","url":null,"abstract":"<p><strong>Introduction: </strong>Pathogenic variants located in genes involved in telomere homeostasis (telomere-related genes [TRGs]) are associated with cases of familial pulmonary fibrosis (FPF). The aim of our study was to characterize the clinical presentation and prognosis of patients with FPF according to the presence or absence of a pathogenic variant involving a TRG.</p><p><strong>Methods: </strong>We conducted a retrospective, observational, single-center study including all patients with FPF followed at the Rare Lung Diseases Reference Center of Bichat-Claude-Bernard Hospital (Paris, France) and analyzed between 2021 and 2024, using next-generation sequencing of a single 30-gene panel associated with FPF.</p><p><strong>Results: </strong>Fifty-six patients were included. Median age at diagnosis of interstitial lung disease (ILD) was 65 years. Thirty-three patients (59%) exhibited a CT pattern of usual interstitial pneumonia (UIP), four (7%) had a nonspecific interstitial pneumonia (NSIP) pattern, and three (5%) displayed a bronchiolocentric interstitial pneumonia pattern. The diagnoses retained after multidisciplinary discussion (MDD) were as follows: idiopathic pulmonary fibrosis in 29 patients (52%), hypersensitivity pneumonitis in four (7%), ILD associated with rheumatoid arthritis in four (7%), and idiopathic NSIP in three (5%). A pathogenic TRG variant was detected in 12 patients (21%): TERT (n=4), PARN (n=4), RTEL1 (n=3), and TERC (n=1). The frequency of pulmonary and extrapulmonary manifestations at diagnosis did not differ significantly between patients with or without a pathogenic TRG variant. Patients carrying a pathogenic TRG variant underwent more rapid annual decline in forced vital capacity (-4.54 vs. -1.75 percentage points; P=0.044).</p><p><strong>Conclusion: </strong>These results confirm the unfavorable prognostic impact of an identified pathogenic variant of a TRG in patients with FPF, which is associated with a particularly rapid decline in respiratory function.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149335191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[The role of immune checkpoints in idiopathic pulmonary fibrosis: An emerging therapeutic paradigm].","authors":"D Pokhreal, D G Helou","doi":"10.1016/j.rmr.2026.09.003","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.09.003","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease for which therapeutic options remain limited. Recent research has highlighted the involvement of immune checkpoints, a class of receptors that have revolutionized cancer immunotherapy, in the regulation of IPF development. This mini-review aims to summarize current knowledge on the role of these immune checkpoints in IPF, including PD-1/PD-L1 and CTLA-4, as well as other receptors such as TIM-3, VISTA, TIGIT, LAG-3, ICOS, TREM-2, and the SIRPα/CD47 axis. Strategically targeting some of these immune checkpoints could offer a promising therapeutic approach to slow the progression of fibrosis in IPF.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Chour, N Beljebbar, L Rivard, L Chalabreysse, M Duruisseaux, T Pierret
{"title":"[Genomic alterations in thymic epithelial tumors: State of knowledge, and the interest of liquid biopsy].","authors":"A Chour, N Beljebbar, L Rivard, L Chalabreysse, M Duruisseaux, T Pierret","doi":"10.1016/j.rmr.2026.08.001","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.08.001","url":null,"abstract":"<p><strong>Introduction: </strong>In the absence of randomized phase III trial data, thymic epithelial tumors (TETs) are rare malignancies of the prevascular mediastinum managed according to the WHO histological and the Masaoka-Koga classifications.</p><p><strong>State of the art: </strong>Next-generation sequencing has revealed distinct mutational characteristics between thymomas, which are characterized by a low tumor mutational burden and a near-specific GTF2I mutation, and thymic carcinomas which are dominated by alterations in CDKN2A, TP53 and KIT. These findings open the way for novel therapeutic strategies, involving immune checkpoint inhibitors and multi-kinase inhibitors in advanced thymic carcinomas. Notwithstanding the potential of liquid biopsy as a non-invasive monitoring tool, specific biological obstacles in TETs currently limit its clinical applicability.</p><p><strong>Perspectives: </strong>Recent confirmation of the interest of liquid biopsy in perioperative management of lung cancer raises the prospect of transferring this approach to TETs. The key challenge lies in identifying the biological marker most suited to the monitoring of longitudinal tumors.</p><p><strong>Conclusions: </strong>Genomic profiling of TETs enhances (rather than supplants) the historical histological classification, and should progressively inform therapeutic stratification, particularly in cases of thymic carcinoma.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R Fragneau, C Paillat, V Berti, M-P Debray, P Mordant, C Taillé, A Guyard, M Garinat
{"title":"[Cancer or chronic infection: Diagnostic challenges of pulmonary botryomycosis].","authors":"R Fragneau, C Paillat, V Berti, M-P Debray, P Mordant, C Taillé, A Guyard, M Garinat","doi":"10.1016/j.rmr.2026.06.002","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.06.002","url":null,"abstract":"","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S Gephine, O Le Rouzic, F Alexandre, D Bajon, M Beaumont, A Bellocq, F Caron, C Chenivesse, B Chehere, Y Darolles, M Decavele, B Degano, J Delemazure, R Gauthier, J Gonzalez-Bermejo, V Gounant, M Guecamburu, A Guerder, L Hajouji, M Hayot, N Heraud, F Herengt, A Lino, A Martin, F Maltais, H Ouksel, J Pernot, G Prieur, G Reychler, S Stelianides, E Villot Danger, M Zysman, F Costes, J M Grosbois
{"title":"[Pulmonary rehabilitation: A 2026 updated expert consensus].","authors":"S Gephine, O Le Rouzic, F Alexandre, D Bajon, M Beaumont, A Bellocq, F Caron, C Chenivesse, B Chehere, Y Darolles, M Decavele, B Degano, J Delemazure, R Gauthier, J Gonzalez-Bermejo, V Gounant, M Guecamburu, A Guerder, L Hajouji, M Hayot, N Heraud, F Herengt, A Lino, A Martin, F Maltais, H Ouksel, J Pernot, G Prieur, G Reychler, S Stelianides, E Villot Danger, M Zysman, F Costes, J M Grosbois","doi":"10.1016/j.rmr.2026.09.007","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.09.007","url":null,"abstract":"<p><strong>Introduction: </strong>The effectiveness of pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease is supported by a high level of evidence. More recently, the indications for PR have expanded and new models of care have emerged.</p><p><strong>State of art: </strong>This position statement summarizes recent evidence on PR regarding: 1) its objectives; 2) the key outcomes to be assessed at baseline, during, and at the end of the program, along with the recommended assessment tools; 3) its integration within the care pathway; 4) modalities of implementation, including home-based programs, telerehabilitation, and hybrid formats; 5) its core components, based on therapeutic education (including psychosocial and motivational support), exercise training, and adapted physical activity; and 6) the strategies and professionals involved in maintaining long-term benefits.</p><p><strong>Perspectives: </strong>The extension of PR indications to other respiratory conditions (interstitial lung diseases, pulmonary hypertension, thoracic oncology) and the development of new delivery models are expected to facilitate PR access.</p><p><strong>Conclusion: </strong>This position statement from French-speaking experts aims to support greater recognition of PR and to promote its integration into patient care pathways.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F Garcin, G O Tsiambanizafy, A Pirvu, G Dubois, S Blaise
{"title":"[When pulmonary sequestration is hidden behind arteriovenous pulmonary malformation].","authors":"F Garcin, G O Tsiambanizafy, A Pirvu, G Dubois, S Blaise","doi":"10.1016/j.rmr.2026.09.004","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.09.004","url":null,"abstract":"<p><p>A 33-year-old patient was stabbed, causing a perforating thoracic wound complicated by cardiorespiratory arrest due to hemorrhagic shock. Emergency surgery was performed with hemostatic and resuscitative bithoracotomy, revealing an incidental lesion suspected of being a pulmonary arteriovenous malformation (PAVM). This lesion being organized, and following embolization of the abnormal arteries arising from the descending thoracic aorta which were causing a systemic-pulmonary shunt, left lower lobectomy was performed. After anatomopathological study, a diagnosis of intralobar pulmonary sequestration was established. Pulmonary sequestration is not included in the international classification of vascular abnormalities. It is defined as a condition in which parts of pulmonary tissue are irrigated by an abnormal systemic artery. There exist two forms of pulmonary sequestration: intralobar and extralobar. Contrarily to most arteriovenous malformations, surgical excision is generally recommended, even though transcatheter embolization could be considered as an option in specific situations. Differential diagnosis of PAVM is difficult and raises questions on risks of progression, which differ between the two pathologies. While transcatheter embolization is a key component of PAVM treatment, radical surgery is usually required for pulmonary sequestration.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149184343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Management of pulmonary infections due to non-Aspergillus filamentous fungi].","authors":"L Chantelot, É Sitterle, G Reichert, A Serris","doi":"10.1016/j.rmr.2026.07.011","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.07.011","url":null,"abstract":"<p><p>Given the increased complexity of immunosuppressive treatments, the prolonged survival of immunocompromised patients, and widespread use of anti-Aspergillus prophylaxis, over recent years the incidence of pulmonary infections caused by non-Aspergillus filamentous fungi has increased. Mucorales represent the most frequently isolated group, followed by Fusarium and Scedosporium, with prevalence varying significantly in different geographic regions and clinical contexts. Although overall incidence remains low, intrinsic resistance to many antifungal agents markedly heightens the mortality associated with these infections. Generally medical as well as surgical, management comprises immunosuppression reduction whenever possible. In this context, enhanced understanding of the epidemiological, diagnostic, and therapeutic characteristics of these rare fungi is essential to achievement of improved patient outcomes.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[What role do corticosteroids play in the treatment of community-acquired pneumonia?]","authors":"P-F Dequin","doi":"10.1016/j.rmr.2026.09.006","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.09.006","url":null,"abstract":"<p><p>Some of the immediate, medium-term, and long-term complications of acute community-acquired pneumonia are correlated with the degree of inflammation in the initial phase, particularly when it is dysregulated. Among the treatments designed to control this inflammation, corticosteroid therapy has been the most extensively studied. Randomized trials conducted in hospitalized patients have generally shown faster improvement with corticosteroids and prevention of subsequent worsening. In patients admitted to intensive care units, and despite conflicting trial results, meta-analyses conclude - with a low level of evidence - that there is a reduction in one-month mortality without an increase in the incidence of hospital-acquired infections. The incidence of hyperglycemia is increased with corticosteroid therapy and is likely a barrier to their use outside of intensive care units. In influenza, data from observational studies suggest excess mortality and lead to the contraindication of corticosteroids outside of therapeutic trials. In the future, treatment will likely need to be individualized based on clinical and biologic parameters, particularly the inflammatory syndrome and immunological phenotyping.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E Driencourt, B Daunou, L Massara, A Ollivier, G Kervoaze, C Godart, M Djouina, M Body-Malapel, P Gosset, M Pichavant
{"title":"[The impact of post-exposure Streptococcus pneumoniae infections on pulmonary immunity: The role of air pollution and IL-20 cytokines in respiratory infections].","authors":"E Driencourt, B Daunou, L Massara, A Ollivier, G Kervoaze, C Godart, M Djouina, M Body-Malapel, P Gosset, M Pichavant","doi":"10.1016/j.rmr.2026.07.009","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.07.009","url":null,"abstract":"<p><p>Air pollution is responsible for more than 9 million premature deaths a year, including 48,000 in France. Fine particles (PM2.5), derived mainly from urban traffic, penetrate deeply into the lungs and trigger oxidative stress and inflammation, their key mechanisms of toxicity. They contribute to cardiorespiratory and systemic damage, increasing the risk of asthma attacks, chronic obstructive pulmonary disease (COPD) exacerbations, and respiratory infections. It is therefore essential, using experimental models, to decipher the mechanisms underlying these infection-related vulnerabilities, the objectives being to better understand the impact of PM2.5 on pulmonary immunity and to limit the repercussions of air pollution.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L Massara, G Kervoaze, A Ollivier, M Pichavant, L Saber-Cherif, S Pons, U Maskos, V Dormoy, P Gosset
{"title":"[Nicotinic receptor polymorphism amplifies cigarette smoke-induced inflammation in COPD, a silent epidemic].","authors":"L Massara, G Kervoaze, A Ollivier, M Pichavant, L Saber-Cherif, S Pons, U Maskos, V Dormoy, P Gosset","doi":"10.1016/j.rmr.2026.07.008","DOIUrl":"https://doi.org/10.1016/j.rmr.2026.07.008","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is the third leading cause of mortality and morbidity. Recent studies on genetic polymorphism highlight the CHRNA5/3/B4 locus, coding for nicotinic subunit receptors such as rs16969968 polymorphism (α5SNP), as genetic determinants of pulmonary vulnerability, acting independently of smoking intensity. We have demonstrated that altered α5 nicotinic receptor expression influences epithelial differentiation, promotes inflammation, and drives airway remodeling. These findings point to a functional role of the pulmonary nicotinic system in COPD pathogenesis and underline the need for precision medicine approaches combining genetic, environmental, and clinical markers so as to better predict disease risk and develop relevant preventive strategies.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}